Reference
EMA. EMA starts evaluating the use of Kineret in adult COVID-19 patients at increased risk of severe respiratory failure Internet Document : 19 Jul 2021. Available from: URL: https://www.ema.europa.eu/en/news/ema-starts-evaluating-use-kineret-adult-covid-19-patients-increased-risk-severe-respiratory-failure
Rights and permissions
About this article
Cite this article
EMA assessing safety of anakinra in adults with COVID-19. Reactions Weekly 1866, 2 (2021). https://doi.org/10.1007/s40278-021-99698-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-99698-3